Hill March 1, 2024
A judge on Friday granted the federal government’s request for summary judgment against AstraZeneca in its lawsuit challenging Medicare negotiation, finding that the drugmaker lacked standing to sue over the program.
In his opinion, U.S. District Judge Colm Connolly found that AstraZeneca had failed to properly establish its standing in filing a lawsuit against the federal government to block Medicare drug price negotiations.
AstraZeneca filed a motion for summary judgment in September asking that the judge find the federal government’s definitions of a “qualifying single source drug” and “bona fide marketing” under the Inflation Reduction Act to be contrary to the law.
Drugs chosen for negotiation could not have any generic competition, like AstraZeneca’s diabetes medication Farxiga, which was chosen...
Today's Sponsors
Today's Sponsor